本页面由Tiger Trade Technology Pte. Ltd.提供服务

杰龙

1.34
-0.0600-4.29%
盘后1.34-0.0050-0.37%19:49 EST
成交量:550.05万
成交额:745.46万
市值:8.55亿
市盈率:-11.15
高:1.43
开:1.40
低:1.33
收:1.40
52周最高:3.99
52周最低:1.04
股本:6.38亿
流通股本:5.34亿
量比:0.50
换手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-0.1201
每股收益(LYR):-0.2702
净资产收益率:-29.57%
总资产收益率:-7.79%
市净率:3.44
市盈率(LYR):-4.96

数据加载中...

公司资料

公司名字:
杰龙
交易所:
NASDAQ
成立时间:
1990
员工人数:
229
公司地址:
919 East Hillsdale Boulevard,Suite 250,Foster City,California,United States
邮编:
94404
电话:
传真:
- -
简介:
Geron Corporation于1990年11月28日在特拉华州成立。该公司是一家生物制药公司,开发用于癌症治疗的一流治疗办法。Imetelstat是一种新奇的、一流的端粒酶抑制剂,是该公司临床发展中的产品的候选人。端粒酶使肿瘤细胞维持端粒的长度,这为无限的细胞复制提供了能力。Imetelstat是一种有效的特异性端粒酶抑制剂。在2012年底的所获得的临床数据的基础上,可能发展Imetelstat用来治疗一种或多种造血系统髓系恶性肿瘤,如骨髓纤维化,或MF,骨髓增生异常综合征,或急性髓细胞性白血病。使用该公司专有的核酸化学,所设计的Imetelstat是用来修饰寡核苷酸,端粒酶的活性位点有高亲和力,从而直接抑制端粒酶活性。公司所开发Imetelstat和美国商业专利权覆盖延伸到2025。

董事

名称
职位
Elizabeth G. O'Farrell
Chairman
Harout Semerjian
President and Chief Executive Officer and Director
John F. McDonald
Independent Director
Robert J. Spiegel
Independent Director
Susan M. Molineaux
Independent Director
V. Bryan Lawlis
Independent Director
Dawn C. Bir
Director

股东

名称
职位
Harout Semerjian
President and Chief Executive Officer and Director
Michelle J. Robertson
Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
Shannon T. Odam
Senior Vice President and Chief People Officer
Edward E. Koval
Executive Vice President and Chief Business Officer
Faye Feller
Executive Vice President and Chief Medical Officer
Joseph Emile Eid
Executive Vice President, Research and Development
Melissa A. Kelly Behrs
Executive Vice President, Business Operations and Chief Alliance Officer
Scott A. Samuels
Executive Vice President, Chief Legal Officer and Corporate Secretary